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ABSTRACT: Microglia and non-parenchymal mac-
rophages located in the perivascular space, the meninges
and the choroid plexus are independent immune populations
that play vital roles in brain development, homeostasis, and
tissue healing. Resident macrophages account for a signifi-
cant proportion of cells in the brain and their density
remains stable throughout the lifespan thanks to constant
turnover. Microglia develop from yolk sac progenitors, later
evolving through intermediate progenitors in a fine-tuned
process in which intrinsic factors and external stimuli com-
bine to progressively sculpt their cell type-specific transcrip-
tional profiles. Recent evidence demonstrates that non-
parenchymal macrophages are also generated during early
embryonic development. In recent years, the development of
powerful fate mapping approaches combined with novel
genomic and transcriptomic methodologies have greatly
expanded our understanding of how brain macrophages
develop and acquire specialized functions, and how cell pop-
ulation dynamics are regulated. Here, we review the tran-
scription factors, epigenetic remodeling, and signaling
pathways orchestrating the embryonic development of
microglia and non-parenchymal macrophages. Next, we
describe the dynamics of the macrophage populations of the
brain and discuss the role of progenitor cells, to gain a better
understanding of their functions in the healthy and diseased
brain. VC 2017 Wiley Periodicals, Inc. Develop Neurobiol 78: 561–579, 2018
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INTRODUCTION
Microglia and brain macrophages are myeloid linage
cells strategically located throughout the brain paren-
chyma and barrier regions (i.e., perivascular space,
meninges, and choroid plexus), where they ingest and
degrade dead cells, debris, and foreign material and
orchestrate inflammatory processes (Ransohoff &
Cardona, 2010) (Fig. 1). The study of their special-
ized functions and the dynamics of these distinct pop-
ulations should contribute to advance our current
knowledge about their role in disease, and may open
new avenues for the development of novel targeted
therapies. In this review, we will discuss the mecha-
nisms governing commitment of primitive myeloid
progenitors to a tissue-specific macrophage fate, with
a focus on brain-resident macrophages, and elaborate
on the dynamics and functions of these distinct
populations.
EMBRYONIC ORIGINS OF THE BRAIN-
RESIDENT MACROPHAGES
Microglia and other resident macrophages of the cen-
tral nervous system (CNS), including perivascular,
meningeal, and choroid plexus macrophages, origi-
nate during primitive hematopoiesis from prenatal
erythromyeloid precursors (EMPs) found in the yolk
sac (Schulz et al., 2012; Hashimoto et al., 2013; Kier-
dorf et al., 2013a; Gomez Perdiguero et al., 2015;
Hoeffel et al., 2015; Sheng et al., 2015; Goldmann
et al., 2016). All brain macrophages, with the excep-
tion of choroid plexus macrophages, are maintained
locally throughout adulthood by self-renewal (Gold-
mann et al., 2016; Askew et al., 2017; Reu et al.,
2017; Tay et al., 2017) (discussed in greater detail in
“Macrophage population dynamics in the adult brain”
Section). Embryonic hematopoiesis starts at the yolk
sac around embryonic day (E) 7.5 and microglial pre-
cursors cells reach the neuroepithelium by E9.5–10
(Alliot et al., 1999; Ginhoux et al., 2010). Immuno-
phenotyping analyses have revealed that uncommit-
ted EMPs express specific markers such as CD311
and c-Kit1 (Kierdorf et al., 2013a). EMPs develop
via the macrophage ancestor population A1 (CD451,
CX3CR1low, F4/80low) into the A2 (CD451,
CX3CR1hi, F4/80hi) progenitor population that com-
mit to microglial cells (Kierdorf et al., 2013a). Simi-
lar observations were made in tamoxifen-dependent
Cre transgenic mouse lines under the control of the
colony stimulating factor-1(CSF-1R) or Runx1
promoters, where Ginhoux and colleagues further
uncovered the existence of two waves of temporally
separated and functionally distinct EMPs that emerge
in the yolk sac between E7.5 and E8.5. The first of
these waves emerges from E7.5 and consist of CSF-
1Rhi, c-Myb- EMPs that give rise to yolk sac macro-
phages that will colonize the embryonic brain rudi-
ments to generate microglia (Hoeffel et al., 2015;
Hoeffel & Ginhoux, 2015; Ginhoux & Guilliams,
2016).
In contrast to the unequivocally established origin of
microglial cells, the ontogeny of non-parenchymal mac-
rophages has remained less clear. Whereas until
recently, macrophages at brain interfaces were tought to
mainly develop postnatally from short-living blood
monocytes that are quickly replaced by bone marrow-
derived cells, new evidence using powerful genetic
fate-mapping approaches and single-cell transcriptomic
profiling, indicates that non-parenchymal macrophages
share a common ontogenetic origin with microglia but
still represent a distinct specialized populations of tissue
macrophages (Goldmann et al., 2016). Loss of function
experiments in knockout mice further demonstrated that
the development of microglia and macrophages at brain
interfaces is independent of the master transcription fac-
tor Myb, but largely depends on transcription factors
like Runx1, Pu.1, and interferon regulatory factor
8 (Irf8) (Kierdorf et al., 2013a; Goldmann et al., 2016).
New efforts are granted to further expand our knowl-
edge on the embryonic hematopoietic niche where
primitive progenitors expand and differentiate during
development to generate the distinct populations of
non-parenchymal macrophages of the brain. The gener-
ation of novel genetic tools with high temporal resolu-
tion will allow for a better understanding of the
ontogeny of tissue-resident macrophages including
macrophages at brain interfaces.
SPECIFICATION OF BRAIN-RESIDENT
MACROPHAGES DURING
DEVELOPMENT
In recent years, the development of fate mapping
approaches combined with next-generation sequenc-
ing and, more recently, the advent of single-cell
genomics, has led to a crucial turning point in our
understanding of how brain’s resident macrophages
develop and acquire specialized functions (Prinz
et al., 2017). Microglia and non-parenchymal brain
macrophages (meningeal, perivascular, and choroid
plexus macrophages) develop from precursor cells that
evolve through intermediate progenitors in a fine-
tuned process in which intrinsic factors and external
stimuli combine to progressively sculpt their genome
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architecture through epigenetic mechanisms leading to
cell type-specific transcriptional profiles (Crotti and
Ransohoff, 2016; Prinz et al., 2017) (Fig. 2).
Master Regulators of the Fate and
Differentiation of Brain Macrophages
During the developmental journey from progenitors
to brain macrophages, a relatively small number of
transcription factors, including RUNX1 (Runt-related
transcription factor 1), PU.1, and IRF8, orchestrate
lineage commitment of yolk sac myeloid precursors
in brain macrophages (Prinz & Priller, 2014; Prinz
et al., 2017). These transcription factors act in a com-
binatorial manner to promote the acquisition of cell
fate and the maintenance of cellular identity (Heinz
et al., 2015).
Runx1 is expressed in the hematopoietic precursors
of the yolk sac (North et al., 1999; Samokhvalov
et al., 2007) where it is a direct target of the master
regulator of hematopoiesis SCL/TAL1 (Stem cell
leukemia/T-cell acute lymphoblastic leukemia 1)
(Landry et al., 2008). The Runx1 gene locus has been
critical in cell-tracing experiments to demonstrate
that parenchymal brain macrophages arise from
primitive myeloid progenitors originated from extra-
embryonic yolk sac (Ginhoux et al., 2010; Zusso
et al., 2012). Similar to observations in other cell
types of the myeloid lineage, RUNX1 regulates pro-
liferation of microglial cells and differentiation to the
ramified morphology typically observed in the adult
forebrain (Zusso et al., 2012). A new experimental
study carried out in mice and humans shows that
RUNX1-binding motif is enriched at the enhancer
landscape of adult mouse and human microglia cells
(Gosselin et al., 2017). Another master transcription
factor for microglia and macrophage development is
PU.1, a myeloid lineage-determining factor that
belongs to Class III ETS family of transcription fac-
tors (Klemsz et al., 1990; Wei et al., 2010). Pu.1 is a
major downstream target gene of RUNX1 during
embryonic haematopoiesis (Huang et al., 2008). Mice
lacking PU.1 show complete absence of microglia
and other CNS macrophages, without affecting the
stem cell compartment (c-Kit1 EMP cells) (Beers
et al., 2006; Kierdorf et al., 2013a; Goldmann et al.,
2016). In Zebrafish, during embryonic myelopoiesis,
Pu.1 and Runx1 are regulated by a negative feedback
loop that governs cell commitment between distinct
myeloid fates (Jin et al., 2012). The third major criti-
cal transcription factor playing critical roles in cell-
fate decisions of myeloid cells is IRF8 (Holtschke
Figure 1 Diversity of myeloid cell types in the adult CNS. The CNS is filled with a variety of resi-
dent innate immune cells that regulate homeostasis and execute surveillance tasks. Microglia cells tile
the entire brain in a contiguous and essentially non-overlapping manner that is orderly and well orga-
nized to actively screen the brain parenchyma for incoming threats. Three other major types of brain-
resident macrophages are present in the outer boundaries of the brain, such as the perivascular space,
choroid plexus, and in the meninges where it is thought they constitute the first line of host defense
against cellular or pathogenic components. [Color figure can be viewed at wileyonlinelibrary.com]
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et al., 1996). Early studies on myeloid differentiation
in the adult hematopoietic system demonstrated that
IRF8 regulates the acquisition monocytic/macro-
phage fate (Scheller et al., 1999; Tamura et al., 2000;
Hambleton et al., 2011). Irf8 knockout in mice and
zebrafish results in impaired microglia development
(Kierdorf et al., 2013a; Shiau et al., 2015). Prinz and
colleagues have shown that IRF8 can act both inde-
pendently and as heterodimeric partner of PU.1 to
regulate the differentiation of microglia from yolk
sac precursors (Kierdorf et al., 2013a). Whereas Pu.1
knockout mice are devoid of microglia, Irf8-ablated
mice show an overall reduction of microglia density
(Kierdorf et al., 2013a). Irf8 knockout yolk sac show
a dramatic reduction in EMP-derived macrophage
ancestor population A2, but preserved levels of A1
cells, suggesting a role of IRF8 in maturation of inter-
mediate progenitors toward mature microglia (Kier-
dorf et al., 2013a). Interestingly, the few remaining
A2 cells in Irf8 knockout mice can still proliferate
and give rise to a microglia population in the adult
that is only slightly decreased as compared with
wild-type mice (Kierdorf et al., 2013a). Parenchymal
macrophages in the adult brain of Irf8-deficient mice
display reduced ramification and lower morphologi-
cal complexity, and altered levels of microglial
markers such as Iba1 (Minten et al., 2012). In line
with these data, a recently published transcriptome-
based profiling of yolk sac-derived macrophages has
shown a critical role of IRF8 on the maturation
throughout development and adulthood of microglia
and other types of tissue-restricted macrophages
(Hagemeyer et al., 2016). IRF8 is also critical for the
development of meningeal macrophages whereas
choroid plexus macrophages develop normally under
IRF8 deficiency (Goldmann et al., 2016). In addition
to these master regulators, recent genomic experi-
ments have suggested a role for the transcription fac-
tors SALL1 (Spalt like transcription factor 1),
SALL3 (Spalt like transcription factor 3), MEIS3
(Meis homeobox 3), and MAFB (MAF BZIP tran-
scription factor B) in development and function of
developing and adult microglia (Mass et al., 2016,
Matcovitch-Natan et al., 2016; Gosselin et al., 2017).
So far, loss of function experiments has clearly estab-
lished a role for SALL1 in the regulation of microglia
phenotype and function (Buttgereit et al., 2016). Butt-
gereit et al. (2016) found that SALL1 is expressed
exclusively in microglia and that microglia-specific
deletion of Sall1 triggers phenotypic transition to an
inflammatory reactive state. These data strongly suggest
that, under physiological conditions, SALL1 is actively
repressing a transcriptional gene program that maintains
microglia steady-state. Although the progress in the
field has been significant in the last years, a better
understanding of the regulatory program that controls
development of microglia is needed. Future research
will further elucidate the nuances promoting precise
control of microglial fate by master regulators. Only
very recently we have begun to understand the develop-
ment and differentiation of non-parenchymal brain
macrophages, and much work remains to be done to
understand their exact nature and origin.
Enhancer Selection Drives Acquisition
and Maintenance of Tissue-Resident
Macrophage Identity
Differentiation from progenitor and intermediate cell
types to fully differentiated brain macrophages
requires the timely control of gene expression and
Figure 2 From EMP to microglia. Microglia arise early
during development from EMP in the embryonic yolk sac
that seed the mouse brain rudiment around E9.0 upon com-
mitment to immature macrophage cells showing ameboid
morphology and a high proliferation rate (also known as A
cells; Bertrand et al., 2005). Amoeboid cells persist during
the first 2 weeks of the postnatal brain where they gradually
acquire the ramified shape characteristic of the active
microglia in the steady state. Commitment of EMP through
immature ameboid macrophages, towards differentiate
microglia is regulated by intrinsic genetic programs and
environmental signals. Initially, a small subset of master
regulators of macrophage development, including, PU.1, C/
EBPs, RUNX1, and IRF8, cooperatively drives specification
and fate acquisition of EMPs into immature macrophages. In
the brain, environmental factors such as CSF1, IL34, and
TGFb play fundamental roles in shaping, maintaining, and
reinforcing microglial identity. Recent genome-wide analy-
ses have identified several transcription factors that are spe-
cific or highly enriched in microglia. These include SALL1,
SALL3, MEIS3, and MAFB. However, their roles in micro-
glia biology remain to be elucidated. To date, SALL1 have
been shown to maintain microglia identity and to regulate
phenotypic plasticity. [Color figure can be viewed at
wileyonlinelibrary.com]
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this is intimately linked with epigenetic mechanisms.
In the genome, distant acting cis-regulatory sequen-
ces or enhancers are bound by transcription factors
and co-activators to enhance the transcription of
an associated gene. Enhancers are structurally and
functionally defined by presence of specific post-
translational modifications on the core histone tails of
the chromatin. Monomethylation of H3K4 (H3K4me1),
and the concomitant presence of H3K27 acetylation dis-
criminate strong from weak enhancers (H3K27ac)
(Heintzman et al., 2007, 2009; Creyghton et al., 2010).
Increased DNA accessibility and CBP/p300 binding are
other distinctive features of active enhancers (Kim
et al., 2010; Visel et al., 2013) Tissue- and cell type-
specific signatures of active enhancers were identified
by genomic studies comparing many tissues and cell
types (Shen et al., 2012, Thurman et al., 2012). More-
over, evidence supports that enhancers and super-
enhancers—large clusters of enhancers—play key roles
in the acquisition and maintenance of cell identity
(Rada-Iglesias et al., 2011; Hnisz et al., 2013; Whyte
et al., 2013; Adam et al., 2015). With approximately
12,000 active promoters, mouse macrophages contain
between 35,000 and 45,000 epigenetically marked
enhancer regions (Ghisletti et al., 2010; Heinz et al.,
2010; Kaikkonen et al., 2013). Although all cell types
express hundreds of transcription factors, a large frac-
tion of functional enhancers are characterized by the
presence of a relatively small set of lineage determining
transcription factors. In the case of macrophages, these
include PU.1, AP-1, and C/EBPs (Ghisletti et al., 2010;
Heinz et al., 2010). Seminal studies comparing perito-
neal macrophages and splenic B cells have shown that
macrophage specific cis-regulatory elements are bound
by the pioneer transcription factor PU.1, which
facilitates the subsequent binding of other lineage-
determining factors including C/EBPs, IRF8, and AP-1
at adjacent locations, and the deposition of H3K4me1,
to confer transcriptional function to cell type-specific
distal regulatory elements (Heinz et al., 2010). Using
wisely designed experiments relying on naturally occur-
ring genetic variation between different inbred mouse
strains as an “in vivo mutagenesis screen”, they found
that polymorphisms at strain-specific PU.1-bound
enhancers were highly enriched in comparison with
strain-similar PU.1-bound enhancers (Heinz et al.,
2013). Together, these data strongly suggest a hierarchi-
cal model, in which macrophage-specific enhancer
selection by PU.1 required collaborative interactions
with additional macrophage-restricted lineage-deter-
mining transcription factors (Heinz et al., 2010, 2013).
Recent evidence indicates that PU.1-bound sites in the
genome of human and mouse microglia are largely con-
served and correspond to genomic regions of open
chromatin associated with methylated histones
H3K4me2 and H3K27ac. Moreover, these regulatory
regions were found to be enriched in motifs for IRF,
AP-1, MEF2, C/EBP, and RUNX (Gosselin et al.,
2017). This study extends previous findings in peritoneal
macrophages to mouse and human microglia and pro-
vide novel insights on the fundamental role of PU.1 in
the establishment of the enhancer landscape of microglia
cells (Gosselin et al., 2017). Again, very little is known
about the genomic landscape of cis-regulatory elements
present in other types of brain macrophages. The identi-
fication of the specific and shared enhancers across the
different populations of brain macrophages will greatly
contribute to our understanding on their specific func-
tions in the healthy and diseased CNS.
miRNA Control of Brain Macrophage
Differentiation and Function
A recently discovered factor controlling the epige-
netic landscape is microRNAs (miRNAs), which have
long been known to regulate development. Several
miRNAs, including miR-124, miR-155, and miR-414
have been shown to modulate the development of
monocytes in the bone marrow. miR-124 is a brain
specific miRNA that is expressed in microglial cells.
It has been proposed that miR-124, by directly inhibit-
ing C/EBPa and PU.1, prevents microglia from acqui-
sition of a reactive phenotype (Ponomarev et al.,
2011). A microglial miRNAs signature has been
recently identified in mice and humans (Butovsky
et al., 2014). New experiments are needed to elucidate
the roles of this subset of miRNAs unique or highly
expressed in microglial cell. Meanwhile, recent data
stress the relevance of miRNAs in microglia biology
and show that interfering with biogenesis of miRNAs
results in spontaneous microglia activation and accu-
mulation of DNA damage in postnatal microglia,
though density is unaltered (Varol et al., 2017). Avail-
able evidence confirms that miRNAs are key regula-
tors of development and function of microglia cells.
However, much work remains to be done to under-
stand their roles and complex mechanisms of action.
MECHANISMS REGULATING IDENTITY
AND PLASTICITY OF BRAIN
MACROPHAGES
Tissue macrophages are extraordinarily versatile cells
with remarkable functional and morphological diver-
sity. In the case of microglia, functional diversity
encompasses surveillance of the surrounding micro-
environment, phagocytosis during tissue remodeling
Development and Maintenance of the Brain’s Immune Toolkit 565
Developmental Neurobiology
(e.g., synaptic pruning) and debris clearance, neuro-
modulation of neuronal circuitry, and orchestration
of innate and adaptive immune responses (Gomez-
Nicola & Perry, 2015). There is growing evidence
that tissue-specific factors from local microenviron-
ment dictate the functional states of developing and
adult tissue-resident macrophages (Amit et al., 2016;
Glass & Natoli, 2016)
External Cues Involved in Differentiation
and Maintenance of Brain Macrophages
Environmental signals received from nutrients,
growth factors, cytokines, and cell–cell interactions
are integrated by specific signaling pathways to mod-
ulate cell differentiation, growth, maturation and ulti-
mately, to enforce fate decisions. The development
of microglia is regulated by factors such as CSF-1,
interleukin 34 (IL-34), and transforming growth fac-
tor beta (TGF-b), which exert their actions during the
early and late stages of primitive haematopoiesis.
These factors have been recently identified as pri-
mary components promoting survival of microglia ex
vivo (Butovsky et al., 2014; Bohlen et al., 2017).
Mice deficient in TGF-b in the brain show an impor-
tant reduction of microglial cells beginning at E14.5
(Butovsky et al., 2014). This reduction was associ-
ated to an increase in apoptosis of these cells sugges-
ting a role of TGF-b in microglia survival and
maintenance in vivo (Butovsky et al., 2014). CSF-1,
IL-34 and its receptor, CSF-1R, are important regula-
tors of the differentiation of most macrophage popu-
lations both during development and in adult mice
(Prinz et al., 2017). During primitive haematopoiesis
CSF-1R is required for the development and differen-
tiation of EMP into microglia (Dai et al., 2002;
Ginhoux et al., 2010; Erblich et al., 2011). Csf-1r
knockout mice are not viable and show complete
absence of tissue macrophages, including microglia
(Dai et al., 2002; Ginhoux et al., 2010; Erblich et al.,
2011). CSF-1R ligands CSF-1 and IL-34, seem to
play redundant roles on CSF-1R-dependent signalling
in microglial cells and tissue macrophages (Ginhoux
et al., 2010; Greter et al., 2012; Wang et al., 2012).
Mice that harbor a spontaneous mutation in the Csf-1
locus, Csf-1op/op mice (Yoshida et al., 1990), leading
to CSF-1 deficiency, show altered morphology and
mild reduction in the number of microglial cells, sim-
ilarly to other tissue-resident macrophages (Wegiel
et al., 1998; Ginhoux et al., 2010). On the other hand,
IL-34 deficiency causes a approximately 40% reduc-
tion of microglial numbers, displaying certain degree
of anatomical variability (Greter et al., 2012; Wang
et al., 2012). Evidence also indicates that DAP-12, a
CSF-1R and TREM-2 adaptor protein, plays a role in
microgliogenesis (Nataf et al., 2005; Otero et al.,
2009). Both DAP-12 and TREM-2 are expressed in
microglia, as well as immature dendritic cells and
osteoclasts (Colonna, 2003). DAP-12-deficient mice
show delayed post-natal differentiation and migration
of microglia into the CNS, whereas adult microglia
show normal densities (Nataf et al., 2005). In contrast
to these data, a study using a different Dap-12 knock-
out mouse line has reported reduced density of micro-
glial cells in the basal ganglia and spinal cord of aged
(10-month-old) mice (Otero et al., 2009). In humans,
recessive mutations in DAP-12 or its associated cell-
surface receptor TREM-2 cause Nasu-Hakola Dis-
ease, which is characterized by frontal dementia and
bone cysts (Paloneva et al., 2000, 2002). Collec-
tively, these data represent solid evidence of the
important role of these growth factors in the regula-
tion of differentiation and maintenance of microglia.
However, the downstream mechanisms by which
these endogenous differentiation factors exert their
effects and whether they differentially influence the
development and function of the distinct types of
brain macrophages remains to be elucidated.
Macrophage-Specific Response to
Environmental Signals Depends on the
Activation of Developmentally Primed
Enhancers
Macrophages are extremely plastic cells that quickly
adapt their transcriptional outcome in response to an
alteration in environment. Further, the same stimulus
can trigger the activation of the same signaling path-
way, including the same signal-dependent transcrip-
tion factor (e.g., NF-jB), but different transcriptional
response in different cells. To a large extent, this abil-
ity of the cells to activate a stimulus-regulated tran-
scriptional program in a cell type-specific manner is
achieved by cell type-specific selection of the cis-reg-
ulatory elements during acquisition of a differentiated
cell fate (Ghisletti et al., 2010; Heinz et al., 2010,
2013). Evidence show that in tissue-macrophages,
there is a significant enrichment of DNA-binding
motifs for signal-regulated transcription factors (e.g.,
Liver X receptors [LXRs]) in the vicinity of PU.1
bound sites. Moreover, presence of PU.1 was found
to be required for LXR and TLR- (Toll-like receptor)
dependent gene expression(Heinz et al., 2010, 2013).
These findings were consistent with those observed
in bone marrow macrophages, in which TLR4 trig-
gered recruitment of p300 to genomic locations
exhibiting H3K4me1 (Ghisletti et al., 2010). Collec-
tively, these data indicate that enhancer selection
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during development includes signal-regulated
enhancers that are primed for later activation in
response to environmental input during adulthood,
providing a mechanism driving stimulus- and cell
type-specific transcriptional response (Heinz et al.,
2015; Link et al., 2015; Romanoski et al., 2015).
There is very little work investigating remodeling of
enhancer landscape during microglial activation. A
very recent study has addressed this question in the
context of the immune response in the spinal cord
after sciatic nerve ligation, a model of neuropathic
pain. This study analyses H3K4me1 chromatin mark in
freshly isolated microglial cells in control conditions
and several days after nerve injury to identify persistent
changes driving neuropathic pain. The authors reported
a sustained alteration in the levels of H3K4me1 in a
restricted subset of enhancers (Denk et al., 2016). How-
ever, the choice of H3K4me1 may limit their ability to
identify the extent of reorganization of the genomic
landscape of cis-regulatory elements after nerve injury.
As discussed earlier, H3K4me1 is an epigenetic mark
present, in conjunction with PU.1, at primed enhancers
that are, in this way, bookmarked for a rapid activation,
through recruitment of signal-dependent transcription
factors and deposition of H3K27ac, in response to envi-
ronmental stimulus. In fact, only a small but function-
ally significant, proportion of de novo generated
enhancers (latent enhancers) have been identified in
macrophages in response to stimulus (Kaikkonen et al.,
2013; Ostuni et al., 2013). Our knowledge about the
genomic reorganizations driving inflammatory response
of the brain innate immune cells remains very limited.
Moreover, it comes primarily from other tissue-resident
macrophages outside the CNS.
Local Microenvironment Shapes Brain-
Resident Macrophage Identity and
Plasticity
Growing evidence strongly indicates that environ-
mental factors shape brain macrophages during
development and at steady-state. In the adult, micro-
glia tile the entire brain and have traditionally held to
be a largely homogenous population that serve the
same roles in all brain regions. However, recent data
have challenge this view and instead reveal evidence
suggesting that microglia represent a population of
complex and functionally diverse cells. These studies
show that during postnatal development and through-
out adulthood region-specific phenotypes of micro-
glia emerge and require local cues to be maintained.
Microglia anatomical, lysosome content, membrane
properties, and transcriptome profile differ signifi-
cantly across brain areas (Grabert et al., 2016; De
Biase et al., 2017). Interestingly, local microglia tran-
scriptional signatures are re-established upon genetic
or pharmacological ablation in the adult brain, indi-
cating that local microenvironment continuously
instructs the identity of microglia (De Biase et al.,
2017). In line with these results, it was previously
shown that external signals impinge on the enhancer
landscape and gene expression profile of the local
population of tissue-resident macrophages (Gosselin
et al., 2014; Lavin et al., 2014). Lavin and collabora-
tors have shown that the environment is capable of
reprograming differentiated macrophages when trans-
ferred into a new microenvironment (Lavin et al.,
2014). The authors assessed the chromatin state of
macrophages derived from transplanted adult bone
marrow that replace embryo-derived tissue-resident
macrophages upon lethal irradiation. They found that
4 months after engraftment, the donor transplant-
derived lung, spleen, liver, and peritoneal macro-
phages acquire enhancers found in embryonic macro-
phages in a tissue-specific manner (Lavin et al.,
2014). Further, it has recently been shown that envi-
ronmental perturbations in specific developmental
stages, such as those affecting the microbiome or pre-
natal immune activation, result in impaired microglia
development and alterations in the associated tran-
scriptional profile (Erny et al., 2015; Matcovitch-
Natan et al., 2016). Finally, expression-profiling
comparison demonstrates drastic differences between
microglia isolated immediately ex vivo and in vitro
cultured primary microglia (Butovsky et al., 2014).
In line with these findings, transition of human and
mouse microglia from the brain to tissue culture pro-
motes remodeling of tissue-specific enhancer land-
scape and extensive down-regulation of genes that
are induced in primitive mouse macrophages follow-
ing migration into the fetal brain, consistent with
their induction by local environmental factors (Gos-
selin et al., 2017). Moreover, another study has
revealed that the loss of adult microglia-specific tran-
scriptional signature upon isolation and in vitro cul-
ture is reversed by engraftment of the primary cells
back into an intact brain parenchyma (Bohlen et al.,
2017). Although in vitro techniques and methodolo-
gies to culture tissue-resident macrophages are under
continuous development and improvement (Butovsky
et al., 2014; Bohlen et al., 2017), data above pose
notable questions on the utility of primary cultures of
tissue-resident macrophages and cell lines and urge
caution when comparing and interpreting results
obtained from in vitro experimental systems. These
studies, taken together, highlight the importance of
the microenvironment and constitutes an important
body of evidence showing that microglia require
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sustained interaction with environmental cues to main-
tain their phenotypic identity and plasticity. However,
the molecular mechanisms and the nature of tissue-
specific external signals remain largely unknown. It is
very likely that the tight interaction observed between
microglia and its local microenvironment also occurs in
the case of non-parenchymal macrophages. Whether
environmental cues also shape the phenotype and func-
tions of non-parechymal macrophages of the brain is an
exciting question that awaits further investigation.
MACROPHAGE POPULATION
DYNAMICS IN THE ADULT BRAIN
A solid body of independent evidence overwhelm-
ingly supports that microglial embryonic progenitors
derive from the embryonic yolk sac, as described ear-
lier (Ginhoux et al., 2010; Kierdorf et al., 2013a).
However, for many years there was a strong debate
focused on the peripheral versus central origin of
microglia during embryonic development and in the
adult brain. This long-standing controversy was
finally settled when a series of papers demonstrated
that only when the blood brain barrier (BBB) is open,
such as during irradiation and bone marrow trans-
plantation, circulating monocytes can be found in the
brain parenchyma (reviewed in Ginhoux et al., 2013;
Prinz et al. 2017). Similarly, in several pathological
models microglia-like cells originate from bone mar-
row derived precursors (Flugel et al., 2001; Mildner
et al., 2007; Varvel et al., 2012). In contrast, more
refined experimental approaches using parabiosis, to
create chimeric mice with shared circulation, demon-
strated a constant infusion of monocytes into periph-
eral organs such as the spleen and the liver, but not
into the brain parenchyma under physiological condi-
tions (Ajami et al., 2007). This evidence was later
supported by lineage-tracing studies using different
inducible mouse models in which a fluorescent
reporter originally expressed by yolk sac embryonic
progenitors (CX3CR11, CSF1R1, Runx11, Tie21)
was later found in daughter microglial cells (Ginhoux
et al., 2010; Kierdorf et al., 2013a; Gomez Perdiguero
et al., 2015; Hoeffel et al., 2015). Once the parenchy-
mal origin of adult microglia was established it was
just a matter of time to start the hunt for the mechanism
maintaining their population. This investigation was
also fostered by evidence indicating that adult microglia
are also capable of recover their whole population after
chemical or genetic depletion, prompting to suggest the
existence of a microglial progenitor (Askew et al.,
2017; Bruttger et al., 2015; Elmore et al., 2014). In the
next sections, we will discuss the current knowledge of
the dynamics of the microglial population in the healthy
brain (Fig. 3).
Cell Cycle and Proliferation Rates of
Microglia
Maintenance of the microglial population by slow
turnover of long-lived cells has been assumed for
many years, since Lawson et al. (1992) reported the
turnover of mouse microglia using 3H-thymidine
labeling combined with F4/80 immunohistochemis-
try. The authors observed a substantial increase in the
number of double-labelled (3H-thymidine1 F4/801)
cells between the 1- and 24-h time points, with a
Figure 3 Cell cycle and proliferation rates of microglia.
(A) Calculations of microglial turnover estimate a cell
cycle length of approximately 32 h with S phase lasting
approximately 16 h (Askew et al., 2017). (B) In the adult
brain, the microglial population is maintained by self-
renewal of resident cells with no contribution from periph-
eral bone marrow-derived cells. There is a tight temporal
and spatial coupling between proliferation and apoptosis in
order to maintain a stable cell density throughout lifetime,
leading to a constant reorganization of the microglial land-
scape. (C) Comparison of the microglial proliferation rate
(%) 24 h post-labelling from studies in mice (blue) by Law-
son et al. (1992), Babcock et al., (2013), Askew et al.
(2017), Tay et al. (2017), and in human (red) by Reu et al.
(2017). Note Lawson et al. used 3H-thymidine and esti-
mated a 0.05% proliferation rate by analyzing 2 h after
dosing, instead of the 24 h shown here. Askew et al. used a
single dose of BrdU in 24 h, whilst Tay et al. used cumula-
tive BrdU (1 dose/d) and Babcock et al., used three doses
of BrdU in 24 h (therefore allowing labeling of 1–2 S
phases). Reu et al. used IdU and 14C. [Color figure can be
viewed at wileyonlinelibrary.com]
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lower number of double-labelled cells between 24
and 48 h. It was hypothesized by the authors that
peripheral proliferating macrophages were also
labelled with 3H-thymidine prior to infiltration into
the CNS and differentiation into microglia, thus con-
tributing to population turnover. However, this seems
improbable given the current model of microglial ori-
gin and the unlikelihood of peripheral cells infiltrat-
ing the parenchyma and differentiating into microglia
under physiological conditions. The authors justified
selection of these time points to detect resident cells
that underwent division within the parenchyma (1
and 24 h) or infiltrating cells that underwent division
in the bone marrow prior to migration and differenti-
ation (24 and 48 h). It was assumed that infiltrating
cells would contribute to the population of proliferat-
ing cells in the later time points, thus the total number
of proliferating resident microglia is likely to be
underestimated by this study. Therefore, this data can
now be re-interpreted under a different light. It
appears that there is a peak in microglial proliferation
at 24 h post-labeling, with 0.19% of microglial cells
shown to be proliferating (Lawson et al., 1992). The
reduction in 3H-thymidine labelled cells between 24
and 48 h suggests that a large proportion of micro-
glial proliferation occurs in the first 24 h after label-
ing (Lawson et al., 1992). Lawson and colleagues
recognized the limitations of 3H-thymidine (Rakic &
Sidman, 1970), which may lead to underestimation of
the total number of proliferating cells. Therefore, the
understanding of the turnover of microglia was
incomplete and needed re-evaluation.
This turnover rate has been recently revisited with
state-of-the-art methods. Indeed, pulse-and-chase
labeling with a single injection of the thymidine ana-
log 5-bromo-2’-deoxyuridine (BrdU), which incorpo-
rates in the nascent DNA during the SA phase, has
led to the estimation of 0.7% proliferating microglia
in the mouse brain under steady-state conditions
(Askew et al., 2017). Proliferation rates in the mouse
brain assessed using labeling with Ki67, a commonly
used proliferation marker, were in the same range but
to some extent lower in a separate study (0.3–0.4%)
(Tay et al., 2017), in spite of the fact that Ki67 labels
cells in all active phases of the cell cycle and thus
leads to higher estimation of proliferating cells com-
pared with single BrdU labeling (Kee et al., 2002).
Another approach to analyze microglial population
dynamics is based on chronic two-photon imaging to
assess cell duplications. Using c-retroviral vectors,
which infect only dividing cells, and daily imaging over
a 10–22-day period led to the estimation of a microglial
proliferation rate of 0.8% (Askew et al., 2017). How-
ever, another two-photon study using inducible sparse
tagging and tracking of individual microglia over pro-
longed periods of time, thanks to low dosing of tamoxi-
fen, suggested instead an extremely low turnover rate
(Fugger et al., 2017). By imaging the same cells every
2 weeks (until 6 months of age) or every month (from 6
months of age), the authors estimated the a proliferation
rate of 0.13%. The discrepancy between these studies
may arise from the imaging schedule, as the 2-week
approach from Fulger et al. may miss several cycles of
division and lead to an underestimation of the micro-
glial turnover.
Although these discrepancies produced different
estimations of the number of average rounds of divi-
sion in each microglia over the lifetime of mice and
humans, as will be discussed in the next section, they
both indeed demonstrate that under physiological
conditions the microglial population undergoes active
self-renewal at low rates. In the human brain, micro-
glial proliferation rates are similarly low. Gomez-
Nicola’s group reported a 2% proliferation rate based
on Ki67 staining (Askew et al., 2017), whereas Fris-
en’s group reported microglial proliferation rates of
0.14% using iodo-deoxyuridine labeling and 0.08%
using retrospective C14 labeling in microglia purified
by magnetic-activated bead sorting (Reu et al., 2017).
Importantly, the proliferation rate of microglia is
around 100 times lower than for peripheral immune
cells, such as granulocytes or monocytes (Reu et al.,
2017). Although these studies show some discrepan-
cies in the absolute turnover rates of microglia, they
agree on a model of active and slow microglial turn-
over, which enables few cycles of renewal of the
whole microglial population in a lifetime. It will be
useful to see these studies on microglial turnover rep-
licated with alternative approaches
In addition, further studies are also needed to
understand the cell cycle dynamics of microglia, as
the duration of the S phase during mitosis is directly
related to the probability of detection of proliferating
cells. Indeed, the shorter the S phase, the fewer cells
would be labelled with BrdU thus resulting in an
underestimation of the microglial cells undergoing
mitosis. Estimations of the cell cycle using a BrdU
time course have suggested that the S phase probably
lasts around 16 h under steady-state conditions
(Askew et al., 2017). As in most cell types the S
phase encompasses 50% of the whole cycle, it was
estimated that microglia would undergo mitosis in
approximately 32 h (Askew et al., 2017). This would
be in agreement with reported cell cycle lengths of mac-
rophages, which vary depending on differentiation stage
from 20 to 40 h (Kueh et al., 2013). Similarly, a recent
study that analyzed microglial proliferative response
after facial nerve axotomy showed a seven 7-fold
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increase in the number of cells from Day 2 to 7, which
was compatible with approximately 3 divisions in 5
days. From these data a cell cycle of roughly 40 h dur-
ing facial nerve axotomy (Tay et al., 2017), similar to
the 32-h cell cycle estimated in steady state conditions
(Askew et al., 2017). However, more precise methods
using double labeling with different halogenated forms
of deoxyuridine such as chloro-dU and iodo-dU (Enci-
nas et al., 2011), or cytometric analysis of DNA content
using dyes such as Hoechst (Kim & Sederstrom, 2015)
would help to precisely estimate the duration of the dif-
ferent phases of mitosis of microglia in health and dis-
ease. Overall, it would be of interest to import concepts
and techniques from the stem cell field into future stud-
ies on microglial turnover.
Importantly, the proliferation of microglia is spatially
and temporally coupled with microglial apoptosis, in
order to keep constant their density (Askew et al.,
2017). Many of the newborn microglia seem to have a
short life time, as they have a higher probability of
death in the first 5 days of cell life as determined by
chronic two-photon imaging (Askew et al., 2017). In
agreement, the rate of new microglia appearing and dis-
apearing were very similar in chronic two-photon imag-
ing experiments (Fuggert et al., 2017) and very few cell
duplications are observed in the long term (36 weeks)
after multicolor genetic lineage tracing using Microfetti
mice, in which Confetti labeling is under the control of
the CX3CR1 promoter (Tay et al., 2017). Similarly, the
early study by Lawson et al. observed roughly equal
numbers of labelled proliferating microglia and apopto-
tic (pycknotic) microglia, supporting the notion that
many newborn microglia undergo cell death. Interest-
ingly, newborn neurons too have similar high death
rates in the first few days of life, both during embryonic
development (de la Rosa & de Pablo, 2000) and in adult
neurogenic niches (Sierra et al., 2010). However, we
have little understanding of the molecular determinants
of the coupling of microglial apoptosis and prolifera-
tion, and how these could provide a substrate for
chronic dysregulation of the microglial population.
Is Microglial Turnover Maintained by
Progenitors?
The idea of the existence of a nestin1 microglial pro-
genitor cell residing in the adult brain has been
recently put forward based on repopulation studies.
Nestin is an intermediate filament that is characteris-
tically expressed in embryonic and adult neural stem
cells and whose function has been related to their
self-renewal (Bellucci et al., 2011). Nonetheless, nes-
tin has a wider expression in embryonic skeletal and
cardiac muscle, liver, and kidney among other tissues
(Neradil & Veselska, 2015). It seems to be particu-
larly linked to mitosis, as is expressed by several pro-
liferative cell types, from reactive astrocytes (Sierra
et al., 2015) to vascular endothelial cells (Suzuki
et al., 2010). Importantly, nestin is also considered a
marker of cancer stem cells from neuroepithelial, epi-
thelial, mesenchimal, and even germ cell origin, and
it is used as a prognosis marker for cancer progres-
sion (Neradil & Veselska, 2015). In the steady-state,
nestin is expressed by neural stem cells (Lendahl
et al., 1990), pericytes (Dore-Duffy et al., 2006), and
NG21 oligodendrocyte precursor cells (Walker et al.,
2010) within the CNS, with expression rarely found
in other cell types (Gilyarov, 2008).
The first evidence of nestin expression in microglial
progenitors came from Kim Green’s group (Elmore
et al., 2014), who observed a rapid repopulation of
microglia following an almost complete depletion in
adult mice after oral administration of high doses of
PLX3397 (Pexidartinib), a potent inhibitor of receptor
tyrosine kinases CSF-1R, Kit, and Flt3. This reduced
microglial numbers in the healthy brain by >90%
after 7 days of treatment and almost completely
depleted the population following longer treatment
regimens (Elmore et al., 2014). In this model, the
microglial population began to reconstitute 3 days
after stopping treatment; however, repopulating cells
displayed different morphology and expression of cell
markers from control microglia, including transient
expression of CD34 and c-Kit, markers of HSCs, and
nestin. By 14 days of recovery, microglial numbers,
phenotype and morphology were indistinguishable
from those in control brains (Elmore et al., 2014). The
authors indirectly suggested the existence of an inde-
pendent progenitor cell, which would be expected to
undergo an asymmetric division to generate one sin-
gle daughter microglia cell. In these experiments, a
four-fold increase in microglia was observed just 24 h
after the depletion drug (pexidartinib) (Elmore et al.,
2014). As it would have implied two full mitosis in
24 h (i.e., whole cell cycle of 12 h), the authors con-
cluded that the repopulated cells must have come
from an independent, unidentified cell type which
after three days expressed nestin (Elmore et al.,
2014). To further support the existence of a hidden
progenitor, Elmore et al., performed a BrdU pulse-
and-chase labeling experiment two days after the
depletion. In an early time point (5 h), they observed
that only 30% of the proliferating cells were micro-
glia, whereas at later time points (24 h) virtually all
proliferating cells were microglia, leading them to
suggest that they must have originate from the
remaining 70%, which was not characterized. There
are however alternative interpretations. Indeed if
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absolute numbers of cells are used to analyze the
transfer of the BrdU load, the data shows a larger
number of BrdU microglia at 5 h than at 24 h, making
unnecessary the existence of an independent progeni-
tor to justify the number of BrdU microglia at 24 h. In
addition, the decrease observed between 5 and 24 h
could result from dilution of the BrdU label, which
cannot be assessed because the BrdU concentration
was not reported (Elmore et al., 2014); or from early
death of the proliferating cells, as has indeed been
shown by two-photon imaging (Askew et al., 2017).
Similar results were obtained after transgenic abla-
tion of microglia: the microglial population is rapidly
reconstituted by proliferation of resident cells. The
use of a CX3CR1CreEr-based system crossed with an
inducible diphtheria toxin receptor system allowed
specific ablation of microglial cells following tamoxi-
fen and diphtheria toxin injections (Bruttger et al.,
2015). An 80% reduction in microglia was observed
3 days after induction, but after 14 days cell numbers
returned to baseline levels. In agreement with the
pharmacological depletion model, after the trans-
genic ablation of microglia pools of resident cells,
which rapidly proliferate to colonize the parenchyma,
rapidly reconstituted the population. These CNS-
derived microglia also expressed nestin; however,
this expression was transient and has no longer seen
once cell numbers returned to normal at Day 14.
In contrast, nestin expression has not been
observed in proliferating microglia in steady-state
conditions using nestin-GFP mice (Askew et al.,
2017). It is important to note that the fluorescent
reporter has a long life in this mouse strain (longer
than the actual nestin protein), leading to its detection
in daughter cells originated from the nestin1 neural
stem cells (Encinas & Enikolopov, 2008), therefore
increasing the probability of detection of nestin in
microglial progenitors. In addition, lineage tracing of
nestin-expressing neuroprogenitor cells has never
been reported to produce microglial cells, at least in
the hippocampus, neither at baseline or disease con-
ditions (Encinas et al., 2011, Sierra et al., 2015).
Therefore, the putative expression of nestin, a typical
ectodermal marker, in microglial progenitors and
whether its expression is exclusively related to their
proliferative response, to depletion, or to more physi-
ologically relevant paradigms remains to be deter-
mined. With these ideas in mind, it is possible that
expression of nestin on microglia is induced only fol-
lowing disruption of population homeostasis, as
microglial expression of nestin under physiological
conditions has not yet been reported (Hickman et al.,
2013; Butovsky et al., 2014; Grabert et al., 2016). Fur-
thermore, the cytokine storm observed by Bruttger
et al. highlights how far from a physiological system
these paradigms are, as the inflammatory milieu of the
CNS is markedly affected following massive micro-
glial cell death. Therefore, these data suggest that
nestin expression in microglia reflects a transient repo-
pulating phenotype, rather than a subpopulation of
“microglial progenitor cells” (Waisman et al., 2015).
Regardless of the nestin expression, the key ques-
tion underlying these studies is whether every micro-
glia has the capacity to self-renew or there is a
microglial progenitor cell. Direct evidence of micro-
glia self-renewing in steady state conditions was
obtained using chronic two-photon imaging, during
which microglia were observed to proliferate and
give rise to two identical daughter cells, which
became ramified and distanced from each other over
a 3-week period (Askew et al., 2017). These results
suggest that at least in physiological conditions all
microglia have the ability to self-renew, undergoing
symmetric divisions to give rise to identical daughter
(microglial) cells. Similar conclusions were reached
using Microfetti mice, where computational Monter-
calo simulations supported a model where every
microglia had the ability to self-renew, instead of
microglial turnover being dependent on microglial
progenitors (Tay et al., 2017). Similarly, the authors
observed that following axotomy evenly distributed
clusters of two to four daughter microglial cells were
generated, suggesting that clonal expansion of micro-
glia and not a specialized microglial progenitor was
sufficient to produce the increased number of cells
after acute injury (Tay et al., 2017). Finally, mathe-
matical modeling of microglial turnover in the human
brain using retrograde 14C labeling was consistent
with a homogeneous proliferation of microglia but
not with the proliferation of a subpopulation of quies-
cent, long-lived progenitor cells (Reu et al., 2017).
In summary, the quest for the microglial progeni-
tors remains on. Although direct evidences using
two-photon imaging and lineage tracing analysis
strongly support that every microglia cell has the
capacity to self-renew, the intriguing possibility that
a yet unidentified cell type which would act as a pro-
genitor remains to be more directly examined in
terms of marker expression, location, cell cycle
dynamics, and recruitment under different physiolog-
ical and pathological conditions.
THE ADDITIONAL BRAIN INNATE
IMMUNE TOOLKIT: PERIVASCULAR,
MENINGEAL, AND CHOROID PLEXUS
MACROPHAGES
Although it is common to refer to microglia as “the
brain immune cells”, there are indeed several other
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populations of resident macrophages located in stra-
tegic barrier regions: the perivascular space, the
meninges, and the choroid plexus. Interestingly, the
repertoire of immune cells residing in the brain’s
interfaces is much complex than previously assumed,
as recently defined by Korin et al. (2017) using
CyTOF mass cytometry. The na€ıve brain contains
subsets of CD8 T cells, B cells, NK cells and den-
dritic cells, residing at the meninges, choroid plexus
and parenchyma (Korin et al., 2017). For simplicity,
in this section we will focus on the populations of
brain macrophages. Early papers used irradiation and
bone marrow chimeras to search for the brain antigen
presenting cells (APCs), that is, the cells that in con-
ditions such as multiple sclerosis would be responsi-
ble for interacting with lymphocytes to activate the
adaptive branch of the immune response. These
papers suggested that brain APCs were located in the
perivascular space and originated from the bone mar-
row (Hickey & Kimura, 1988; de Groot et al., 1992).
However, as discussed earlier, irradiation leads to
inflammation, opening the BBB, and leading to the
leaking of circulating monocytes with bone marrow
origin (Kierdorf et al., 2013b). An improved bone
marrow transplantation method was developed to
reduce inflammation, where mice received low doses
of irradiation and both syngenic hematopoietic and
mesenchymal stem cells are injected intra-bone mar-
row (IBM) (Hasegawa-Ishii et al., 2013). Using this
method, bone-marrow GFP-labelled cells were found
in the leptomeninges and choroid plexus as early as 2
weeks, followed by clusters of bone marrow cells in
small but growing numbers from 1 to 8 months in
discrete areas of the brain parenchyma, such as habe-
nula, amygdala, hippocampus, and cerebellum. As
these regions are very close to choroid plexuses, the
authors suggested a novel entry point to the brain
parenchyma of bone marrow cells followed by local
expansion by proliferation (Hasegawa-Ishii et al.,
2013). The replenishment of choroid plexus macro-
phages from circulating cells has also been demon-
strated using genetic lineage tracing and parabiosis
(Goldmann et al., 2016). However, the IBM study did
not directly assessed BBB opening or inflammation
(Hasegawa-Ishii et al., 2013). The lack of differentia-
tion of bone marrow cells into parenchymal microglia
under non-inflammatory conditions is strongly sus-
tained by the literature (Ginhoux et al., 2010; Kier-
dorf et al., 2013a; Gomez Perdiguero et al., 2015;
Hoeffel et al., 2015) but nonetheless the provocative
hypothesis that in some circumstances circulating
precursors may enter the parenchyma through the
choroid plexus deserves further testing. Furthermore,
more experiments are required to determine the rate
of replacement of choroid plexus macrophages from
bone marrow cells, their half-life, and their differenti-
ation program.
In contrast to choroid plexus macrophages, peri-
vascular and meningeal macrophages originate from
the embryonic yolk sac just like microglia, as com-
pellingly demonstrated by parabiosis and lineage
tracing of CX3CR1 expressing cells at P9 up to 10
months (Goldmann et al., 2016). Perivascular macro-
phages in the spinal cord are maintained by self-
renewal even during inflammation induced by auto-
immunity with myelin-derived peptides (Goldmann
et al., 2016). Following research on microglia, further
studies will determine whether these cells retain pro-
liferative properties and renew their population over
the lifetime.
Functions of Perivascular, Meningeal,
and Choroidal Macrophages
These sets of resident macrophages have been largely
disregarded into oblivion, but recent research has
shed light into their relevant roles in the perivascular
space, meninges, and choroid plexus (Herz et al.,
2017). A key feature is their location at the so-called
“brain interfaces”, which act as communicating brid-
ges between the brain parenchyma and the outside.
The best known barrier, the BBB, is formed
between the blood and the brain parenchyma. The
BBB is a highly selective barrier formed by tight
junctions on the endothelial cells of the brain
capillaries; a perivascular space separating the basal
membrane of these capillaries where both pericytes
and perivascular macrophages reside; and the termi-
nal feet of parenchymal astrocytes (Daneman, 2012).
Brain vascularization begins during early embryonic
development at E11 in mice and is followed by the
recruitment of pericytes, which are essential for the
establishment of the BBB, at around E13.5 (Daneman
et al., 2010). Pericytes were long though to derive
from either neural crest cells or mesenchymal cells in
the blood vessels although it has been suggested that
a subpopulation derives from differentiated macro-
phages expressing F4/80 and CD31 during initial
brain vascularization (Yamamoto et al., 2017). These
events are followed by the recruitment of yolk sac
precursors from E9 to E16 to form perivascular mac-
rophages, although the precise timing remains to be
determined (Goldmann et al., 2016). Finally, astro-
cytes are recruited to the BBB 1 week after birth
(Daneman et al., 2010).
The roles of perivascular macrophages have been
poorly studied. These elongated cells are very similar
to microglia in their expression of markers such as
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Iba1, CD11b, Csf1R (CSF receptor 1), and CX3CR1
(Goldmann et al., 2016; Sierra et al., 2007). Perivas-
cular macrophages had a very similar transcriptional
profile compared with microglia, but clearly different
from circulating monocytes (Goldmann et al., 2016).
In the adult brain, perivascular macrophages are pre-
sumed to be involved in immune surveillance (Dane-
man, 2012), possibly related to their continuous
retraction and protraction of processes along blood
vessels (Goldmann et al., 2016). They play a protec-
tive role during bacterial infection by regulating the
recruitment of circulating leukocytes (Polfliet et al.,
2001), although their role during neurodegenerative
conditions in which BBB is altered remains to be
determined (Daneman, 2012). Interestingly, develop-
mental defects in CSF1R signaling lead to defective
pericyte coverage of brain vessels (Yamamoto et al.,
2017), suggesting a role of perivascular macrophages
in BBB establishment.
The BBB is also closely related to the meninges,
which encompass three layers of connective tissue:
the external dura, facing the skull; and the arachnoid
and pia (leptomeninges), separated by the subarach-
noid space infused with cerebrospinal fluid, and
through which blood vessels penetrate the brain
parenchyma (Coles et al., 2017). Leptomeningeal
epithelial cells associate to large blood vessels only,
at least in the human brain (Coles et al., 2017).
Meninges are established in the early embryonic
development around E9–E10 in the mouse brain.
Dural cells derive from the mesoderm and are related
to the skull bones, whereas leptomeningeal cells
derive from the neural crest (Siegenthaler & Pleasure,
2011; Goldmann et al., 2016). Importantly, it was
recently discovered that meninges possess a system
of lymphatic vessels whose structure is largely simi-
lar to blood vessels, comprising endothelial cells, but
through which interstitial fluid and immune cells
(lymph) flow towards deep cervical lymph nodes
(Louveau et al., 2015). This so-called “glymphatic”
system connects the cerebrospinal fluid with the
peripheral immune system and has been suggested to
play a role in the clearance of brain waste products,
such as bAmyloid (Raper et al., 2016). Importantly,
little is known about meningeal macrophages. Resi-
dent macrophages originated in the yolk sac during
embryonic development with ameboid morphology
and motility have been described in the mouse
meninges (Goldmann et al., 2016), but their particu-
lar location in the dura and/or leptomeninges is
unknown, possibly due to the reduced size of mouse
meninges (Raper et al., 2016). Meningeal macro-
phages have also been observed in human meninges,
but whether they are part of the glympathic system is
unknown (Louveau et al., 2015). Interestingly, mac-
rophages instruct lymphangiogenesis during develop-
ment by regulating proliferation of lymphatic
endothelial cells in the peripheral immune system
(Gordon et al., 2010), raising the possibility that brain
meningeal macrophages play similar roles. In addi-
tion, during autoimmune diseases such as experimen-
tal autoimmune encephalomyelitis, a mouse model of
multiple sclerosis, the meninges are an important site
of antigen presentation to T cells (CD41), performed
both by resident macrophages and dendritic cells
(Kivisakk et al., 2009). Yet, many fundamental ques-
tions about the location and function of meningeal
macrophages under steady state and pathological
conditions remain unanswered.
A second barrier is formed between blood and
cerebrospinal fluid and is sustained by tight junctions
between epithelial cells in the choroid plexus (Engel-
hardt & Sorokin, 2009). Choroid plexus are evolu-
tionarily conserved, highly vascularized structures
that protrude into the brain ventricles as well as the
subarachnoid space (Bill & Korzh, 2014). Choroid
plexus are made of epithelial cells specified from the
neuroectoderm as early as E10.5 in the mouse
embryo (Liddelow, 2015). In addition, the choroidal
stroma includes several cell types such as fibroblasts,
neural stem cells, telocytes (a novel type of intersti-
cial cell with long and thin processes and regenera-
tive properties), as well as circulating lymphocytes
and resident macrophages (Bill & Korzh,
2014).These macrophages are initially seeded from
the yolk sac during embryonic development (E9.5–
E16 in mice) but are constantly replaced by bone
marrow derived monocytes throughout adulthood
(Goldmann et al., 2016). The main functions of the
choroid plexus (i.e., barrier maintenance and cerebro-
spinal fluid release) are carried out by epithelial cells.
The cerebrospinal fluid contains many bioactive mol-
ecules whose significance has just begun to be unrav-
eled but seem to be involved in autonomic functions
such as sleep and appetite, neural transmission, brain
development, and a growing list of neurodegenerative
conditions, in addition to providing a hydrostatic
skeleton that absorbs mechanical brain damage (Bill
& Korzh, 2014). The role of choroid plexus macro-
phages has not been fully resolved, but they are
located close to the microvilli of the choroid plexus
(Goldmann et al., 2016) and would be interesting to
assess their contribution to cerebrospinal fluid release
and flux. In addition, choroid plexus are to some
extent related to circumventricular organs (CVOs),
which include secretory (neurohypophysis, pineal
gland, median eminence, subcommisural organ) and
sensory (area postrema, subfornical organ, organum
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vasculosum of the lamina terminalis) CVOs (Kaur &
Ling, 2017). CVOs, separated from the brain paren-
chyma by modified ependymal cells named tanicytes
(Kaur & Ling, 2017), are highly vascularized with
fenestrated capillaries and located adjacent to the
ventricles, and their main function is to release sub-
stances into the cerebrospinal fluid (Bill & Korzh,
2014). All CVOs contain macrophages (Kaur &
Ling, 2017), whose origin and function remains to be
discovered.
CONCLUSION AND PERSPECTIVE
Investigation of the mechanisms governing microglia
and brain macrophage development and function has
come a long way. So far, likely because of their
higher abundance, the vast majority of the studies
have focused on microglia cells. The use of single-
cell RNA sequencing has allowed interrogating the
gene expression profile of the different types of brain
macrophages (Goldmann et al., 2016; Zeisel et al.,
2015). In the future, the combination of emerging
single-cell epigenomic methods interrogating chro-
matin accessibility (scATAC-seq), chromatin histone
modifications (scChIP-seq), and DNA methylation
(scBS-seq) coupled to single-cell gene expression pro-
filing (scRNA-seq) should allow us to capture similari-
ties and differences in gene expression and epigenetic
chromatin landscape also in less abundant cell popula-
tions of non-parenchymal brain macrophages (Small-
wood et al., 2014; Buenrostro et al., 2015; Guo et al.,
2015; Rotem et al., 2015; Angermueller et al., 2016;
Clark et al., 2016). The recent development and wide-
spread adoption of new genome editing techniques
combined with single-cell genomic approaches open
new possibilities including forward genetic screens,
which will undoubtedly contribute to uncover new play-
ers regulating microgliogenesis and development of
non-parenchymal macrophages.
Finally, the role of the different intrinsic factors
and the nature of the external signals that regulate
fate decisions and commitment to differentiation
of progenitors to brain macrophages are not yet
completely understood. Similarly, a variety of envi-
ronmental factors whose identities remain to be iden-
tified, shape and maintain the identity of microglia
and non-parenchymal macrophages across the differ-
ent brain areas. Many aspects of the mechanisms
driving brain colonization and terminal differentia-
tion processes which lead to the generation of distinct
types of brain resident macrophages during early
postnatal stages are only partially understood. Other
questions as to how microglial cells communicate to
each other and distribute within the adult brain to
form a mosaic-like network to scan the surrounding
environment and modulate the neuronal circuitry
underlying brain functions remains enigmatic. The
vibrant and exciting field of immune cells of the brain
and neuroinflammation has recently undergone a
dramatic transformation. However, there are many
fundamental questions that remain unanswered. A
deeper understanding of the mechanisms that regulate
development, maintenance of phenotypic identity,
population dynamics, and function of resident macro-
phages of the adult brain should help clarifying how
these cells react to brain disorders and will offer new
targets to develop novel therapeutic interventions for
these devastating conditions.
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